NRP2 and renal cell carcinoma: For example, both NRP2 and PLXNA1 are significantly upregulated in renal cell carcinoma (the Human Protein Atlas, Fig. S10), which may be a promising target cancer type for therapeutic investigations of P1943-Nb2cL.